II. Epidemiology
- Worldwide Prevalence: 400 Million
- Caucasians of Mediterranean ancestry (Class II)- Greek patients
- Jewish patients
- Sardinian patients (from island of Italy)
 
- Black patients or African descent (Class III)- Up to 10% of U.S. african-American Males have G6PD
 
- Asian patients
- Filipino patients
III. Pathophysiology
- 
                          Glucose-6-phosphate dehydrogenase (G6PD)- Catalyzes NADP to NADPH (pentose phosphate path)
- Thiol glutathione neutralizes free radicals (superoxide, Hydrogen Peroxide, hydroxyl)
- NADPH prevents oxidative damage to cells by regenerating Thiol glutathione after it has been oxidized
- RBCs depend on G6PD for sole pathway to NADPH (since RBCs lack mitochondria)
- RBCs are most susceptible to insufficient G6PD
 
- Methemoglobin (Fe3+) may form spontaneously- Methemoglobin is typically reduced to normal Hemoglobin (Fe2+) by cellular mechanisms
- NADPH is important in combating oxidative stress and converting Hemoglobin back to Fe2+
- However in G6PD Deficiency, this fails and Methemoglobinemia is unchecked
 
- Results in acute Hemolytic Anemia
- Drug-induced Hemolysis affects older cells- Younger cells have adequate enzyme levels to survive
 
- G6PD mutations occur on distal long arm of C Chromosome- X -Linked Disorder
 
IV. Grading: Class Severity (WHO)
- Abnormal- Class 1: Congenital nonspherocytic Hemolytic Anemia (rare)- Most common in white males of european descent
- Hemolysis occurs without oxidative stress exposure
- Splenomegaly is present in 40% of patients
 
- Class 2: Severe G6PD (1 to 10% Enzyme Activity)- More common in mediterranean descent
- Symptomatic Hemolysis with oxidative stress
 
- Class 3: Mild G6PD (10 to 100% Enzyme Activity, most common)- Hemolytic Anemia occurs only with significant oxidative stress
 
 
- Class 1: Congenital nonspherocytic Hemolytic Anemia (rare)
- Normal- Class 4: Nondeficient G6PD Variant (60 to 100% Enzyme Activity)- Common in African Descent
- Asymptomatic, even with oxidative stressors
 
- Class 5: Normal activity (>150% normal Enzyme Activity)
 
- Class 4: Nondeficient G6PD Variant (60 to 100% Enzyme Activity)
V. Causes
- See Medications in G6PD Deficiency- Onset within 72 hours of intake
 
- Infection (most common cause)- Salmonella
- Eschirichia coli
- Beta-hemolytic Streptococcus
- Rickettsia
- Viral Hepatitis
- Influenza A
 
- Fava beans (Italian Broad Beans)- Bell Beans
- Broad Beans
- English Dwarf Beans
- Haba Beans
- Horse Beans
- Pigeon Beans
- Silkworm Beans
- Tic Beans
 
VI. Symptoms and Signs
- Usually asymptomatic
- See Hemolytic Anemia for acute episodes
VII. Differential Diagnosis
VIII. Labs
IX. Complications
- Increased risk of Sepsis
X. Prevention
- Avoid precipitating factors- See Medications in G6PD Deficiency
- Keep Immunizations up-to-date
 
- Treat Anemia following Hemolytic Anemia episode- Iron Supplementation
- Folic Acid supplementation
 
- Measures that are not recommended (no benefit)
XI. References
- Golan in Goldman (2000) Cecil Medicine, p. 873-75
- Beutler (1994) Blood 84:3613-36 [PubMed]
- Bubp (2015) PT +40(9):572-4 +PMID: 26417175 [PubMed]
- Frank (2005) Am Fam Physician 72:1277-82 [PubMed]
- Phillips (2018) Am Fam Physician 98(6): 354-61 [PubMed]
